TRIAL DATA
Aspirin after liver metastasis treatment tested in phase 3 trialThe ASAC trial randomly assigned patients who had undergone curative-intent treatment for colorectal cancer liver metastases to aspirin or placebo to assess whether adjuvant aspirin improves disease-free survival. (Lancet Gastroenterol Hepatol)